Diazepinomicin

N/A

Report date: 2025/07/22 11:31:45
NME

Base Information

Drug NameDiazepinomicin
Drug Alias NameBU-4664LECO-4601TLN-4601ECO-04601AMO-01
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranslocator protein stimulants
TargetsTranslocator protein
Therapy Area/IndicationsPhelan-McDermid syndromeProstatic NeoplasmsLung Neoplasms +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBellus Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPhelan-McDermid syndromeProstatic NeoplasmsLung Neoplasms +[10

Other Information

ATC CodeN/A
Related LinksN/A